The aim of this study was to identify biomedical risk factors for the development of preeclampsia of varying severity in the group of examined pregnant women. Material and methods. 70 women whose pregnancy was complicated by the development of preeclampsia were under observation. The first group included 46 (65.7%) patients with moderate preeclampsia; the second group included 24 (34.2%) women with severe preeclampsia. The diagnosis was established on the basis of the patient's complaints, clinical examination, somatic, obstetric and gynecological anamnesis, analysis of the course of the present pregnancy, ultrasound fetometry and Dopplerometry findings. The patients who participated in the study had an assessment of clinical and anamnestic parameters, somatic status, obstetric and gynecological anamnesis. Data from 45 pregnant women with an unencumbered obstetric and gynecological history and a physiologically occurring pregnancy were used as control values. Results. The prognostic risk factors for the development of moderate and severe preeclampsia were analyzed based on the calculation of relative risk indicators (RR) and 95% confidence interval (95% CI). In the group of pregnant women with both severe and moderate preeclampsia, strong prognostic risk factors were: place of residence in the regions, extragenital pathology in the anamnesis, gynecological diseases in the anamnesis, the number of pregnancies in the anamnesis, birth parity, and arterial hypertension. The early identification of risk factors for moderate and severe preeclampsia enables timely preventive measures, thereby improving patient outcomes and prognosis. Conclusion. The analysis revealed that preeclampsia was more prevalent among pregnant women with a history of various extragenital diseases, a complicated obstetric and gynecological history, and concomitant hypertension.
